Citadel Advisors’s Moringa Acquisition Corp Warrant MACAW Stock Holding History

Citadel Advisors’s Portfolio MACAW Stock Details MACAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-17,805	Closed	-$1.96K	–	15610
2024 Q2	$1.96K	Buy	+17,805	New	+$1.39K	﹤0.01%	13755
2022 Q1	–	Sell	-23,933	Closed	-$13K	–	14818
2021 Q4	$13K	Sell	23,933 -18,562	-44%	-$11.1K	﹤0.01%	13648
2021 Q3	$25K	Buy	+42,495	New	+$29.4K	﹤0.01%	13617

Citadel Advisors's MACAW Position: Q3 2024 in Review

Citadel Advisors sold out of Moringa Acquisition Corp Warrant (MACAW) in Q3 2024, closing a stake of 17,805 shares — an estimated $1.96K sold.

Citadel Advisors first reported a position in MACAW in Q3 2021 and held it in 3 quarters. The position peaked at $25K in Q3 2021. 0 funds tracked by Wall St. Rank hold MACAW as of Q3 2024.

Citadel Advisors reported no remaining Moringa Acquisition Corp Warrant position as of Q3 2024 after selling out during the quarter.
Citadel Advisors sold 17,805 Moringa Acquisition Corp Warrant shares in Q3 2024, an estimated $1.96K.
Citadel Advisors first reported a position in Moringa Acquisition Corp Warrant in Q3 2021 and held it in 3 quarters.
Citadel Advisors's Moringa Acquisition Corp Warrant position peaked at $25K in Q3 2021.
0 funds tracked by Wall St. Rank held Moringa Acquisition Corp Warrant as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.